When President Bush nominated Susan Dudley to head the Office of Information and Regulatory Affairs (OIRA) last year, her nomination didn’t make it out of the Senate committee. (See Celeste Monforton’s post on Dudley’s underwhelming performance before the committee.) Yesterday, Bush avoided Senate opposition by giving Dudley a recess appointment. As head of OIRA, Dudley will […]
This week, health advocates are drawing attention to some important safety hazards. The Senate just passed a resolution proclaiming the first week in April National Asbestos Awarenss Week and urging the Surgeon General, as a public health issue, to warn and educate people that asbestos exposure may be hazardous to their health. Meanwhile, EPA released a new pamphlet educating mechanics about […]
By David Michaels The Prescription Drug User Fee Act (PDUFA), through which the FDA collects money from drug makers in exchange for faster reviews of their new products, gets skewered again â this time in a piece by Christopher Moraff in the American Prospect Online. (We’ve been covering the issue here at TPH; more materials […]
By David Michaels The Wall Street Journal (sub required) is reporting that the White House will bypass the Senate confirmation process and announce later today that President Bush has given a recess appointment to Susan Dudley to head the Office of Information and Regulatory Affairs (OIRA). The office, part of the Office of Management and […]
By David Michaels The campaign by policy experts to have Congress end the user fee system that funds FDA is picking up steam. The Prescription Drug User Fee Act (PDUFA) allows FDA to collect money from drug makers in exchange for faster reviews of their new products. But PDUFA makes the FDA dependent on the […]
A few hours ago, the Supreme Court ruled in Massachusetts vs. EPA that EPA has the authority to regulate carbon dioxide from auto emissions. (For background on the case, see this post.) David Stout of the New York Times summarizes: